 |
Data shows ‘incomprehensible price rises’ Related items from OnMedica 75% of reappraised CDF drugs approved for NHS Rising costs of generic medications Pfizer fined a record £84.2m for overcharging NHS cancer patients still denied treatments available in other countries Study shows huge global variation in cancer drug costs |
Monday, 30 January 2017
UK patients losing out in access to cancer drugs
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment